Nemvaleukin alfa
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Nemvaleukin alfa, covering 2024-03-05 to 2025-08-28. Get the full timeline:
Most recent: Clinical Trial Update: Phase 3 Study of Nemvaleukin Alfa in Combination With Pembrolizumab in Patients With Platinum-Resistant Epithelial Ovarian Cancer (ARTISTRY-7) [Phase 3]